awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40397988-FA35AB32-D3FC-4F8E-9FCF-EF91D862D4DB
Q40397988-FA35AB32-D3FC-4F8E-9FCF-EF91D862D4DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40397988-FA35AB32-D3FC-4F8E-9FCF-EF91D862D4DB
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma.
P2860
Q40397988-FA35AB32-D3FC-4F8E-9FCF-EF91D862D4DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40397988-FA35AB32-D3FC-4F8E-9FCF-EF91D862D4DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebca43fc2011bdcdc6b2ddc7e158129892c5ab40
P2860
FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway